Related by context. All words. (Click for frequent words.) 81 neurodegenerative disorders 77 neurological diseases 76 neurodegenerative disease 72 degenerative diseases 72 neurodegeneration 70 neurodegenerative 70 neurological disorders 69 autoimmune diseases 69 inflammatory diseases 68 metabolic disorders 67 neuro degenerative diseases 66 degenerative disorders 66 autoimmune disorders 65 neuropsychiatric disorders 65 protein misfolding 63 ocular diseases 63 Neurodegenerative diseases 62 neuronal dysfunction 62 inflammatory disorders 62 Parkinson disease Alzheimer disease 62 neuroprotection 62 CNS disorders 62 rheumatoid arthritis multiple sclerosis 62 molecular mechanisms 62 neuropsychiatric diseases 62 therapeutics 61 Hedgehog pathway 61 neurodegenerative disorder 61 autoimmune 61 Alzheimer Parkinson 60 mitochondrial dysfunction 60 excitotoxicity 60 Alzheimer disease Parkinson disease 60 muscular dystrophies 60 Parkinson Alzheimer 60 diseases 60 neuroinflammation 60 pathogenesis 60 pathological hallmarks 60 demyelinating diseases 59 proliferative diseases 59 engineered RAP peptides 59 protein misfolding diseases 59 small molecule inhibitors 59 cholesterol metabolism 59 cellular pathways 59 retinal degenerative diseases 59 LRRK2 59 lysosomal storage diseases 59 metabolic diseases 59 protein tau 58 Hedgehog signaling pathway 58 FTLD 58 molecular chaperones 58 degenerative neurological diseases 58 motor neuron degeneration 58 Autoimmune diseases 58 motor neuron diseases 58 molecular mechanisms underlying 58 tissue fibrosis 58 fibrotic diseases 58 progressive neurodegenerative disorder 58 Wnt signaling pathway 58 cardiovascular disorders 58 epilepsy Parkinson disease 58 immunological diseases 58 amyotrophic lateral sclerosis ALS 58 molecular biomarkers 58 small molecule 58 prion diseases 58 Alzheimer disease AD 58 SOD1 58 Friedreich ataxia 58 amyloid beta plaques 58 lupus multiple sclerosis 58 retinal diseases 58 Prion diseases 58 pathophysiology 58 hyperphosphorylation 58 biomarkers 57 siRNA therapeutics 57 underlying molecular mechanisms 57 synaptic function 57 Alzheimers disease 57 mGluR2 NAM 57 neurofibrillary tangles 57 immuno inflammatory diseases 57 neuropathic pain 57 RNAi therapeutic targeting 57 disease modifying 57 pathophysiological 57 lipid metabolism 57 neuroprotective 57 tau protein 57 tumor suppressor protein 57 neurodevelopmental disorders 57 cardiovascular metabolic 57 pathogenic mechanisms 57 Huntingtons disease 57 TTR amyloidosis 57 neuronal function 57 misfolded proteins 56 selective inhibition 56 inflammatory bowel diseases 56 kidney urologic 56 retinal degeneration 56 synaptogenesis 56 susceptibility genes 56 HDAC inhibitors 56 epigenetic mechanisms 56 Alzheimer disease 56 cardiometabolic disorders 56 carcinogenesis 56 potent inhibitors 56 hematologic diseases 56 protein kinase C 56 immune mediated 56 disorders 56 dysregulation 56 novel therapeutics 56 neuronal degeneration 56 biological pathways 56 retinal disorders 56 TMEM#B 56 microRNAs 56 motor neuron disease 56 apoptotic pathway 56 neurotrophic 56 MAP kinases 56 diabetic nephropathy 56 atherosclerosis 56 molecular pathway 56 sphingolipid 56 neurotransmission 56 neurotrophic factors 56 neuro protective 56 tumorigenesis 56 cardiovascular diseases 55 renal fibrosis 55 neurobiology 55 neural stem cell 55 tauopathies 55 sortilin 55 skeletal muscle weakness 55 NF2 55 amyloid deposits 55 stem cell differentiation 55 cell signaling pathways 55 Duchenne muscular dystrophy DMD 55 psoriasis rheumatoid arthritis 55 galanin 55 chronic inflammatory 55 molecular underpinnings 55 tumor suppressor genes 55 microglial cells 55 synaptic plasticity 55 myeloproliferative disorders 55 diagnostic biomarkers 55 mutant huntingtin 55 neuro degenerative disease 55 intracellular signaling pathways 55 neural disorders 55 biochemical mechanisms 55 ion channels 55 signaling cascades 55 chromosomal rearrangement 55 renal diseases 55 breast cancer metastasis 55 myelination disorders 55 viral diseases 55 neuronal nicotinic receptors NNRs 55 glutamate receptors 55 gene silencing 55 biomarker 55 immunoregulation 55 mitochondrial disorders 55 myelofibrosis polycythemia vera 55 psychiatric disorders 55 rheumatoid arthritis lupus 55 pathological hallmark 55 ophthalmic diseases 55 oncogenesis 55 neuro inflammatory 55 mGluR4 55 genomic instability 55 chromosomal translocations 55 inherited retinal degeneration 55 Pseudomonas aeruginosa infections 55 autoimmune inflammatory 55 neuronal 55 epithelial cancers 55 Parkinson disease multiple sclerosis 54 cachexia 54 P#X# 54 pharmacological chaperone 54 demyelination 54 peroxisomal 54 fibrotic disease 54 small molecule therapeutics 54 signaling pathway 54 antisense drugs 54 cancer therapeutics 54 signaling pathways 54 Smad3 54 anti angiogenesis 54 peptides 54 neuromuscular disorders 54 biologic pathways 54 oncogenes 54 Hsp# inhibition 54 Wnt pathway 54 stem cell biology 54 chronic inflammation 54 MAPK pathway 54 antisense 54 vascular diseases 54 metabolic enzymes 54 anticancer therapeutics 54 hepatic stellate cells 54 neurologic diseases 54 molecular pathways 54 CB2 receptor 54 neurogenesis 54 autoimmunity 54 Age Related Macular 54 neuroinflammatory 54 melanocortin receptors 54 SIRT1 gene 54 ischemic diseases 54 angiogenesis 54 neurologic disorders 54 inflammatory autoimmune diseases 54 adult neurogenesis 54 protein kinases 54 neurogenerative diseases 54 microRNA therapeutics 54 GSK3 54 myopathies 54 Abeta# 54 anemias 54 micro RNAs 54 rheumatoid arthritis psoriasis 54 lysosomal 54 PDE7 54 siRNA delivery 54 VEGF receptor 54 p# pathway 54 Alzheimer Disease AD 54 selective inhibitors 54 neuropathology 54 neuro degenerative disorders 54 histone deacetylase inhibitors 54 RNAi therapeutics 54 liver fibrosis 54 spongiform encephalopathies 54 debilitating diseases 54 therapies 54 nerve degeneration 54 cardiac hypertrophy 54 immunologic diseases 54 activate SIRT1 54 immune modulation 54 NF kappa B 54 hypophosphatasia 54 signal transduction pathways 54 alpha synuclein 54 autoinflammatory diseases 54 protein homeostasis 54 V#F mutation 54 non alcoholic steatohepatitis 54 inherited retinal 54 NNRs 54 hematologic disorders 54 cognitive dysfunction 54 bioactive lipids 54 COX enzymes 54 chronic degenerative diseases 54 autoimmune encephalitis 54 transcriptional regulation 54 mGluR5 antagonist 54 progranulin 54 regulating gene expression 53 cognitive deficits 53 PTP 1B 53 beta amyloid peptides 53 proteins 53 pathophysiologic 53 lung fibrosis 53 Amyotrophic Lateral Sclerosis ALS 53 retinal dystrophies 53 biochemical processes 53 multiple sclerosis Parkinson disease 53 tau tangles 53 resolvins 53 apoE 53 targeted radiotherapeutics 53 preclinical models 53 glial cell 53 molecular abnormalities 53 epigenetic alterations 53 neoplastic diseases 53 targeting PCSK9 53 mutated protein 53 neurodegenerative illnesses 53 degenerative retinal diseases 53 superoxide dismutase 53 neuronal cell 53 calcineurin 53 senile plaques 53 beta amyloid peptide 53 JAK3 53 facioscapulohumeral muscular dystrophy 53 oncolytic viruses 53 genetic biomarkers 53 clusterin 53 Hedgehog signaling 53 small molecule agonists 53 NeuroTrans TM 53 neuronal plasticity 53 antagomirs 53 receptor tyrosine kinases RTKs 53 STAT3 53 neuroprotective properties 53 beta secretase inhibitors 53 neuromuscular junction 53 signal transduction 53 autoimmune disease 53 proliferative disorders 53 antiviral compounds 53 rheumatic diseases 53 amyloid formation 53 CCR3 53 underlying pathophysiology 53 neuroendocrine 53 TLR9 agonists 53 neuropathies 53 biologic therapeutics 53 endocrine diseases 53 SIRT1 53 LIS1 53 HSF1 53 biochemical pathways 53 alpha#beta# 53 Tß4 53 myeloproliferative diseases 53 epigenetics 53 nicotinic alpha 7 53 allergic diseases 53 Factor VEGF 53 Neurodegenerative Diseases 53 lipoprotein metabolism 53 humanized monoclonal antibodies 53 CDK inhibitors 53 oxidative stress 53 amyloids 53 related macular degeneration 53 stem cell therapeutics 53 PDGFR 53 PDGF receptor 53 cell signaling pathway 53 HGPS 53 antibody therapeutics 53 IGFBP2 53 #beta HSD1 53 beta catenin 53 Symadex 53 inherited neurological disorder 53 geographic atrophy 53 histone methyltransferases HMTs 53 GPR# [002] 53 NMDA receptors 53 amyloid protein 53 identify protein biomarkers 53 functional genomics 53 intracellular protein 53 lysosomal storage disorders 53 amyloidogenic 53 NF kappaB pathway 53 neurofibromin 53 progressive neurodegenerative 53 Stargardt Macular Dystrophy SMD 53 podocytes 53 immuno modulatory 53 inherited neurodegenerative disorder 53 PluriCells TM 53 monogenic diseases 53 tumor suppressors 53 tumor suppressor 53 amyloid 53 adenoviral 53 misfolded protein 53 primary cilia 53 investigational therapies 53 sporadic ALS 53 multiple sclerosis psoriasis 53 ocular disorders 52 neurotrophins 52 amyloid proteins 52 Alzheimer disease pathogenesis 52 innate immunity 52 pathophysiological mechanisms 52 ADDLs 52 CCR1 52 VIPR2 52 chronic diseases 52 Skp2 52 MAPK 52 telomere dysfunction 52 RANK ligand 52 phenotypes 52 pathogenetic 52 Alzheimer disease cognitive impairment 52 systemic lupus erythematosus 52 amyloid beta proteins 52 presymptomatic 52 myotonic dystrophy 52 dementias 52 chronic viral infections 52 OPHN1 52 membrane receptors 52 SIRT3 52 nAChR 52 cellular senescence 52 β amyloid 52 kinase inhibitors 52 epigenetic enzymes 52 lipid mediators 52 sirtuin therapeutics 52 frontotemporal dementia 52 neuropsychiatric disorder 52 underlying vasculopathy 52 glutamatergic 52 alpha synuclein protein 52 osteopontin 52 agonist compounds 52 alpha synuclein gene 52 immunobiology 52 synaptic transmission 52 mutant huntingtin protein 52 plasma kallikrein 52 PI3K delta 52 myeloproliferative neoplasms 52 TLR8 52 RNAi therapeutic 52 AT1R 52 genetic determinants 52 nerve cells 52 fibrotic disorders 52 Bryostatin 52 ceroid lipofuscinosis NCL 52 inflammation thrombosis oncology 52 anti amnesic 52 glial tumors 52 axonal damage 52 Hutchinson Gilford progeria 52 peroxisome proliferator activated 52 histone deacetylase 52 molecular mechanism 52 anti angiogenic 52 genetic disorders 52 liver cancers hypercholesterolemia 52 microRNA 52 cognitive functions 52 neuropilin 52 derived neurotrophic factor 52 GRP# 52 transgenic mouse model 52 neural crest 52 therapeutic modalities 52 heritable disorders 52 atherogenesis 52 susceptibility gene 52 dopaminergic 52 neurotrophic factor 52 theranostics 52 neurogenic 52 mitochondrial function 52 ciliopathies 52 serine protease 52 c myc gene 52 sd rxRNA compounds 52 Vascular Endothelial Growth 52 ataxias 52 antisense oligonucleotides 52 Tβ4 52 UCP2 52 epigenetic 52 diabetic retinopathy 52 PI3 kinase 52 immunotherapeutic approaches 52 vascular disorders 52 immunology oncology 52 neural cells 52 epithelial tissues 52 HDAC 52 Autoimmune disorders 52 novel peptides 52 mutant protein 52 Clusterin 52 transgenic mouse models 52 axon regeneration 52 non coding RNA 52 tau aggregates 52 ion channel 52 fibroblast growth 52 systemic amyloidosis 52 hematologic malignancies 52 dysregulated 52 respiratory gastrointestinal 52 NTDDS 52 mitotic catastrophe 52 insoluble plaques 52 sphingolipids 52 RNAi 52 macular degeneration diabetic retinopathy 52 deacetylase inhibitors 52 telomerase activators 52 preclinical 52 hedgehog pathway 52 small molecule activators 52 multiple sclerosis rheumatoid arthritis 52 olfactory dysfunction 52 retinal pigment epithelium 52 GPCR targets 52 Parkinson disease spinal cord 52 cognitive impairment associated 52 receptor agonists 52 Aß 52 protein alpha synuclein 52 β catenin 52 therapeutic monoclonal antibodies 52 cAMP signaling 52 tiapamil 52 Neurological disorders 52 PICALM 52 protein tyrosine phosphatases 52 anticancer drugs 52 protein biosynthesis 52 regenerative medicine 52 nicotinic receptors 52 Genetic variants 52 mitochondrial decay 52 Leber Congenital Amaurosis LCA 52 cypin 52 mitochondrial mutations 52 progranulin protein 52 endophenotypes 52 neurite outgrowth 52 malignant transformation 52 neuritic plaques 52 neuro degeneration 52 HDAC inhibition 52 cMET 52 TLR3 52 GPCRs 52 ERK signaling 52 remyelination 52 autism susceptibility genes 52 NMDA receptor 52 beta amyloid plaques 52 ubiquitin ligases 52 romazarit 52 JNK pathway 52 hormone gastrin 52 cholinergic neurons 52 dermatological disorders 52 autoantigen 52 Friedreich Ataxia FRDA 52 Wnt signaling 52 nNOS 52 FTIs 52 hematological abnormalities 52 cystic fibrosis transmembrane conductance 52 exon skipping 51 tumor metastasis 51 mitogen activated protein kinase 51 DISC1 gene 51 Parkinson disease PD 51 Retinitis pigmentosa 51 anticancer therapy 51 MAP kinase pathway 51 tRNA synthetases 51 osteoclast activity 51 monogenic 51 EGFR pathway 51 Neurofibromatosis type 51 protein beta amyloid 51 myelin repair 51 translational research 51 Parkinsons disease 51 coagulation disorders 51 melanocortin 51 LPA1 receptor 51 small molecule defensin 51 p#INK#a 51 Six3 51 endogenous ligands 51 miR #a [002] 51 Stapled Peptide 51 inflammatory demyelinating 51 Oxidative stress 51 amyloid plaques 51 TGF β 51 familial amyloidotic polyneuropathy FAP 51 transient receptor 51 JAK1 51 immune modulator 51 neuronal differentiation 51 immunomodulatory 51 autoimmune uveitis 51 lysosomal enzyme 51 glial derived neurotrophic 51 NPHP 51 peroxisome 51 neurobiological 51 neuronal signaling 51 leukemias lymphomas 51 tau pathology 51 A3 adenosine receptor 51 micro RNA 51 chromatin remodeling 51 anti angiogenic drugs 51 channelopathies 51 PI3K pathway 51 PI3K 51 RANK Ligand 51 Squalamine 51 prostate carcinogenesis 51 CYT# potent vascular disrupting 51 genotoxic stress 51 anticancer therapies 51 Aβ 51 ENaC 51 carbon nanomaterials 51 NNR Therapeutics 51 allergic inflammation 51 rheumatoid arthritis thrombocytopenia 51 retinal degenerations 51 tumor immunology 51 muscular dystrophy cystic fibrosis 51 HDACs 51 venomics 51 rheumatoid arthritis 51 Abeta protein 51 Alzheimer Disease 51 transdifferentiation 51 chemokine receptors 51 miRNA 51 VEGF inhibitors 51 metabolic abnormalities 51 prognostic markers 51 hematological diseases 51 viral hemorrhagic fevers 51 diabetic kidney 51 myogenesis 51 Alzheimer disease epilepsy 51 metabolic pathways 51 PI3K inhibitors 51 RNAi pathway 51 psoriasis psoriatic arthritis 51 inflammatory bowel disease 51 neuron degeneration 51 lysosomal storage disease 51 Curaxin 51 Oxidative damage 51 leukotriene pathway 51 monoclonal antibodies 51 dermatological diseases 51 nitric oxide synthase 51 cellular signaling pathways 51 gamma secretase 51 Sirtuins 51 intercellular communication 51 proto oncogene 51 macular degeneration 51 fibrosis 51 SIRT1 activators 51 NovaBay Aganocide compounds 51 diabetic retinopathy DR 51 NF1 51 therapeutic monoclonal antibody 51 Behcet uveitis 51 uPA 51 phosphoinositide 3 51 causative genes 51 degenerative neurological disorders 51 predictive biomarkers 51 Phylomer ® 51 tyrosine kinases 51 Cockayne Syndrome 51 Systemic lupus erythematosus SLE 51 Kinases 51 Genetic variations 51 Hsp# [002] 51 RNA silencing 51 antibody therapies 51 JAK2 51 endocannabinoid system 51 GCN2 51 hedgehog signaling 51 essential thrombocythemia 51 dyskeratosis congenita 51 lipid synthesis 51 MELAS syndrome 51 Aviptadil 51 bone morphogenetic proteins BMPs 51 factor receptor FGFR 51 receptor subtype 51 anticancer agents 51 familial ALS 51 mimetics 51 glutamate 51 siRNA compounds 51 CK2 51 TÎ ² 4 51 LDL receptor 51 therapeutic modality 51 chemokines 51 γ secretase 51 Apoptosis 51 apoptosis 51 #ME# 51 Upregulation 51 anti fibrotic 51 molecular signaling pathways 51 GGF2 51 cardiovascular restenosis cancer 51 PARP inhibitors 51 airway remodeling 51 Fibromyalgia Syndrome FMS 51 AMPAKINE compounds 51 CTGF 51 HuLuc# 51 cholinergic 51 Micro RNAs 51 NF kB pathway 51 amyloid deposition 51 enzyme cofactor 51 synaptic dysfunction 51 immunodeficiency disorders 51 sirtuin enzymes 51 NF kB 51 immuno inflammatory 51 degenerative disorder 51 peripheral neuropathies 51 acetonide FA 51 dopaminergic neurons 51 FMRP protein 51 malignant lymphomas 51 AKT1 51 transmissible spongiform encephalopathies TSEs 51 hypoxia inducible factor 51 pro angiogenic 51 S1P 51 inosine 51 vascular inflammation 51 cognitive disorders 51 therapeutic interventions 51 phosphatidylinositol 3 51 Brodmann Area 51 Beta catenin 51 iPSC 51 mitochondrial oxidative 51 bexarotene 51 cellular metabolism 51 regenerative therapies 51 γδ T cells 51 rxRNA 51 MeCP2 protein 51 CCR9 antagonist 51 commercializing therapeutic 51 rare autosomal recessive 51 rxRNA compounds 51 kallikrein 51 hsp# 51 NF kB signaling 51 physiological mechanisms 51 diabetic macular edema 51 c myc 51 kinase 51 dystrophies 51 epigenetic regulation 51 DNA methyltransferases 51 LPA1 50 protein ADNP 50 huntingtin gene 50 Bardet Biedl Syndrome 50 mesenchymal cell 50 amyloidosis 50 Retinopathy 50 SOD1 gene 50 gastric carcinogenesis 50 serine proteases 50 CGEN # 50 neuroprotective effects 50 progressive degeneration 50 pRb 50 chemopreventive agent 50 protein kinase 50 p# gene 50 muscle dystrophies 50 INS# [001] 50 DLX5 50 Peutz Jeghers syndrome 50 protein biomarkers 50 axonal regeneration 50 amyloid beta peptide 50 Enkephalin 50 gastric carcinoma 50 neurotransmitter glutamate 50 autoimmune diseases inflammation 50 novel antibody therapeutics 50 hypoparathyroidism 50 secreted protein 50 anticancer agent 50 tau protein tangles 50 immunotherapeutics 50 pathophysiological processes 50 AMPK activators 50 serotonin receptor 50 chemokine 50 filaggrin 50 epigenetic changes 50 RNA interference 50 neural degeneration 50 ubiquitin ligase 50 amyloid cascade 50 inflammatory cascade 50 Cancer cachexia 50 BMP signaling 50 Misfolded proteins 50 neuroprotective therapies 50 protein kinase inhibitors 50 STK# [002] 50 pharmacological therapies 50 Smurf1 50 receptor ligands 50 thrombotic diseases 50 Ets2 50 arthritis RA 50 kinase pathway 50 pro inflammatory cytokines 50 Psoriatic arthritis 50 mGluRs 50 CD#L 50 Ras pathway 50 retinitis pigmentosa RP 50 Inflammatory bowel diseases 50 C5aR 50 pathologic myopia 50 axonal 50 FLT3 50 Neurodegeneration 50 PKM2 50 hematopoiesis 50 neuroendocrine tumors 50 BRAF gene 50 polyamines 50 Factor VIIa 50 tumor suppressor gene 50 AMPAKINE 50 biased ligand 50 redox active 50 systemic juvenile idiopathic 50 Akt3 50 PDE# inhibitors 50 neuropathic pain metabolic diseases 50 neovascularization 50 NIC5 50 immunoregulatory 50 synapse formation 50 epigenomics 50 Spiegelmers R 50 Frontotemporal Dementia 50 IL 7R 50 chemopreventive 50 Pten 50 splice variants 50 Abeta peptide 50 Syk 50 diabetes cardiovascular disease 50 Amyloid plaques 50 Glucocorticoids 50 protein tyrosine phosphatase 1B 50 organ transplant rejection 50 cell adhesion 50 antisense inhibitors 50 ErbB3 50 BCR ABL inhibitors 50 Htt 50 phosphate S1P 50 commercializes innovative biopharmaceuticals 50 gastrin 50 neurofibromatosis type 50 systemic fungal infections 50 MEK inhibitors 50 rheumatoid arthritis Crohn disease 50 Aurora kinase 50 Leber congenital amaurosis 50 TRPV1 50 PPAR γ 50 neuropsychological disorders 50 renal disease 50 Dr. Bezprozvanny 50 amyloid ß 50 metastatic cancers 50 viral infections 50 immunodeficiencies 50 glial cells 50 neuronal cells 50 Th2 cytokines 50 Neuropathology 50 Janus kinase 50 OXIGON TM 50 druggable target 50 Nanobodies ® 50 pain syndromes 50 kinases 50 neuroinflammatory diseases 50 oxidases 50 biochemical pathway 50 G Protein Coupled 50 oligonucleotide therapeutics 50 NF KB 50 novel therapeutic antibodies 50 cell adhesion molecule 50 RNA interference RNAi 50 antibody mediated 50 gene therapy 50 histone deacetylase HDAC inhibitors 50 noncoding RNAs 50 medulloblastomas 50 receptor antagonists 50 oncogenic 50 protein therapeutics 50 carbohydrate metabolism 50 Hh pathway 50 GI motility disorders 50 Alzheimer Disease Parkinson Disease 50 immune modulatory 50 GPCR 50 somatic mutations 50 Tay Sachs thalassemia 50 receptor subtypes 50 GABA aminotransferase 50 DISC1 50 nanomedicine 50 mTOR 50 Fibroblast Growth Factor Receptor 50 retinal cells 50 demyelinating disease 50 membrane fusion 50 fusion proteins 50 monoclonal antibody therapeutics 50 beta defensins 50 p# MAPK 50 signaling molecule 50 LHON 50 solid tumors 50 PKC beta 50 behavioral abnormalities 50 gastrointestinal cancers 50 Kv#.# 50 tenascin C 50 debilitating neurodegenerative disorder 50 gene fusions 50 epigenetic therapies 50 Hsp# inhibitors 50 proteins misfold 50 sirtuins 50 mutant proteins 50 Curaxins 50 TGF b 50 isoform selective 50 Prodarsan ® 50 enzyme inhibitors 50 miRNAs 50 multiple myeloma MM 50 Myotonic dystrophy 50 nerve regeneration 50 neovascular diseases 50 ibudilast 50 Notch signaling 50 erythropoiesis 50 hemoglobinopathies 50 dendritic spine 50 Amyloid 50 E#F# 50 MicroRNA 50 novel VDA molecule 50 Diabetic neuropathy 50 Prodarsan R 50 PARP inhibition 50 TTR gene 50 fatal neurodegenerative disorder 50 adipose derived regenerative 50 Alzheimer disease frontotemporal dementia 50 nonsense mutations 50 ERK1 2